K
Kain99
Guest
LONDON, England (Reuters) -- There may be more to Viagra than sex.
The iconic blue pill, launched five years ago this month, faces new competition from rivals that claim to act faster and last longer -- but the scientist who led its development says Viagra could have a new lease of life in quite different areas.
Ian Osterloh, based at Pfizer Inc's research center in England, is particularly excited about using the anti-impotence drug to treat pulmonary hypertension, an often deadly form of high blood pressure affecting the lungs.
Researchers are currently conducting a large, intermediate-stage, clinical study on the difficult-to-treat disease and will get a clearer picture on results in 2004.
More Details
The iconic blue pill, launched five years ago this month, faces new competition from rivals that claim to act faster and last longer -- but the scientist who led its development says Viagra could have a new lease of life in quite different areas.
Ian Osterloh, based at Pfizer Inc's research center in England, is particularly excited about using the anti-impotence drug to treat pulmonary hypertension, an often deadly form of high blood pressure affecting the lungs.
Researchers are currently conducting a large, intermediate-stage, clinical study on the difficult-to-treat disease and will get a clearer picture on results in 2004.
More Details